Diabetes & CV Disease

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
08:44

Houston Methodist DeBakey Heart and Vascular Center

What Is the Role of Novel Anti-Diabetic Drugs in Cardiovascular Disease?

FEATURING Imad Hussain
  • 11 views
  • December 9, 2020
09:31

Houston Methodist DeBakey Heart and Vascular Center

Novel Use of Anti-Diabetic Drugs in Heart Failure: What Are the Benefits of SGLT2 Inhibitors?

FEATURING Dale J. Hamilton
  • 202 views
  • December 9, 2020
06:41

Houston Methodist DeBakey Heart and Vascular Center

What Is the Mechanism of Action of New Anti-Diabetic Drugs in Cardiovascular Disease?

FEATURING Dale J. Hamilton, Arvind Bhimaraj, Imad Hussain
  • 11 views
  • December 9, 2020
17:38

Houston Methodist DeBakey Heart and Vascular Center

Novel Use of Anti-Diabetic Drugs in Heart Failure: How Do SGLT2 Inhibitors Work? What Are the Usage Effects?

FEATURING Dale J. Hamilton, Imad Hussain, Arvind Bhimaraj
  • 19 views
  • December 11, 2020
18:41

Christos Argyropoulos

Diabetic Kidney Disease Treatment: When to Use SGLT2 Inhibitors & Who Should Prescribe Them?

  • 1,255 views
  • December 14, 2020
  • 3
37:58

Christos Argyropoulos

Diabetic Kidney Disease & FDA Approved SGLT2 Inhibitors: What Are the Key Pharmacological, Therapeutic, and Safety-Related Properties?

  • 238 views
  • December 14, 2020
28:48

Christos Argyropoulos

Diabetic Kidney Disease: What Is the Role of the Kidney in Glucose Homeostasis?

  • 564 views
  • December 14, 2020
  • 1
08:48

Christos Argyropoulos

Diabetic Kidney Disease: What Are the Current Epidemiological Trends?

  • 580 views
  • December 14, 2020
  • 1
15:21

26th Annual San Diego Heart Failure Symposium

Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?

FEATURING Pam Taub
  • 973 views
  • December 15, 2020
  • 9
20:55

26th Annual San Diego Heart Failure Symposium

SGLT2 Inhibitors and GLP-1 Receptor Agonists for Treating Type 2 Diabetes and Reducing Cardiovascular Risk

FEATURING Pam Taub
  • 895 views
  • December 16, 2020
  • 3
12:16

26th Annual San Diego Heart Failure Symposium

Effects of SGLT2 Inhibitors in Treating Heart Failure Patients Regardless of Their Glycemic Status

FEATURING Gregg Fonarow
  • 255 views
  • December 16, 2020
  • 2
20:17

26th Annual San Diego Heart Failure Symposium

Q&A: Advances in Heart Failure Management

FEATURING Barry Greenberg, Gregg Fonarow, Uri Elkayam, Clyde Yancy
  • 25 views
  • December 17, 2020
07:56

Cardiometabolic Health Congress (CMHC)

CMHC Update on Postprandial Glucose Control: How Can CGM Help Us to Target PPG?

FEATURING Irl Hirsch
  • 125 views
  • December 18, 2020
  • 1
18:33

Cardiometabolic Health Congress (CMHC)

59 y/o Male With Hypertension, Diabetes, CKD, Obesity, and Hypercholesterolemia: What Would Be an Optimal Consideration for the Clinical Care?

FEATURING Ileana Pina, Javed Butler, Matthew Weir
  • 304 views
  • December 21, 2020
  • 3
21:20

Keck School of Medicine of USC

Newer Therapies in Management of Chronic Heart Failure: Roles of SGLT2 Inhibitors and Vericiguat

FEATURING Kruti Pandya
  • 290 views
  • December 28, 2020
09:00

Cardiometabolic Health Congress (CMHC)

63 y/o Male With BP 162/86 mmHg, 84 bpm Heart Rate, Dyspnea, PMH-Hypertension, and T2D: What Would Be the Next Steps in Managing Risk Factors?

FEATURING Rajiv Agarwal, Janet Mcgill
  • 110 views
  • December 28, 2020
  • 1
24:25

Cardiometabolic Health Congress (CMHC)

Diabetic Kidney Disease Management: What Are the Strategies to Slow the Progression, and Effect of Finerenone on CKD Outcomes?

FEATURING Rajiv Agarwal
  • 766 views
  • December 28, 2020
  • 6
18:18

Cardiometabolic Health Congress (CMHC)

Diabetic Kidney Disease ADA Guidelines for Early Recognition & Screening

FEATURING Janet Mcgill
  • 477 views
  • December 28, 2020
  • 4
12:38

Cardiometabolic Health Congress (CMHC)

Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments, Panel Discussion

FEATURING Deepak Bhatt, P. Gabriel Steg, Lawrence Leiter
  • 110 views
  • December 28, 2020
14:40

Cardiometabolic Health Congress (CMHC)

78 y/o Female, Nonsmoker With T2DM, Hypercholesterolemia, Hypertension, and Epigastric Distress: How to Select Antihyperglycemic Agents, and What Are the Strategies for CV Risk Prevention?

FEATURING Lawrence Leiter
  • 65 views
  • December 28, 2020
17:30

Cardiometabolic Health Congress (CMHC)

Prevention of Cardiovascular Events in High-Risk Diabetes Patients With CAD: What Is the Efficacy of Ticagrelor With Aspirin?

FEATURING P. Gabriel Steg
  • 226 views
  • December 28, 2020
10:19

Cardiometabolic Health Congress (CMHC)

What Is the Link Between Diabetes, CAD, and CVD?

FEATURING Deepak Bhatt
  • 94 views
  • December 28, 2020
24:16

Cardiometabolic Health Congress (CMHC)

Metabolic Surgery for Diabetes & CV Disease: Is There a Benefits for Patients Outside NIH Criteria?

FEATURING David Cummings
  • 358 views
  • January 5, 2021
  • 3
08:46

John Tayek

2020 Updates on DM-2 Management: What Is the Efficacy and Safety of Metformin, Ertugliflozin, and Glipizide? When to Recommend Gliflozin?

  • 24 views
  • January 7, 2021
21:28

John Tayek

ADA Standard of Care 2020 Update: What Are the Insulin Therapy Recommendations?

  • 1,072 views
  • January 7, 2021
  • 6

Diabetes & CV Disease

All Topics: